mmcivf ivf clinic
PGTA

PGTA

Preimplantation Genetic Testing for Aneuploidies (PGTA) is a technique used in IVF to screen embryos for chromosomal abnormalities before implantation. It involves biopsying cells from embryos, analyzing them for genetic issues, and selecting the healthiest embryos for transfer to increase the chances of a successful pregnancy.

PGTA needed

When is PGTA needed?

Women over 37 with a history of miscarriage or failed IVF cycles or people with a family history of chromosome problems, may look to use PGTA to help identify euploid embryos and avoid transferring aneuploid embryos.

IVF cycles
Recurrent miscarriages

Recurrent miscarriages

To identify chromosomal abnormalities in embryos.

Multiple failed IVF cycles

Multiple failed IVF cycles

To increase the chances of successful implantation.

Advanced maternal age

Advanced maternal age

The risk of chromosomal abnormalities increases with age.

Family history of genetic disorders

Family history of genetic disorders

To screen embryos for specific genetic conditions.

chromosomal abnormalities

Previous child with chromosomal abnormalities

To reduce the risk of recurrence.

ivf
mmcivf clinic
clinic

How it works

Egg retrieval and sperm collection: Eggs and sperm are collected through traditional methods or assisted by techniques like ultrasound or TESE.

Fertilization: Eggs are fertilized with sperm in a laboratory.

Embryo culture: Fertilized eggs develop into embryos.

Biopsy: A single cell or group of cells is removed from the embryo for testing.

Genetic analysis: The removed cells are analyzed for chromosomal abnormalities.

Embryo selection: Embryos with normal chromosomes are selected for transfer.

Embryo transfer: Selected embryos are transferred to the uterus.

Ready to take next step?

Schedule a consultation with our expert team at MMC IVF. We are here to provide personalized care and support